Empowered Patient Podcast

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs.  This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease. @ValnevaSE #Lyme #LymeDisease  #chikungunya Valneva.com Download the transcript here Additional links: Chikungunya Fact Sheet Lyme Fact Sheet World Health Organization Zika virus resources World Health Organization Japanese encephalitis resources